Global Hepatitis A Vaccine Market Insights and Forecast to 2028

Report ID: 1122809 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hepatitis A Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Inactivated Vaccine
        1.2.3 Live Attenuated Vaccine
    1.3 Market by Application
        1.3.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Hepatitis A Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Hepatitis A Vaccine Sales by Region
        2.4.1 Global Hepatitis A Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Hepatitis A Vaccine by Region (2023-2028)
    2.5 Global Hepatitis A Vaccine Revenue by Region
        2.5.1 Global Hepatitis A Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Hepatitis A Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Hepatitis A Vaccine Sales by Manufacturers
        3.1.1 Global Top Hepatitis A Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis A Vaccine in 2021
    3.2 Global Hepatitis A Vaccine Revenue by Manufacturers
        3.2.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Hepatitis A Vaccine Revenue in 2021
    3.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Hepatitis A Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Hepatitis A Vaccine Sales by Type
        4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Hepatitis A Vaccine Revenue by Type
        4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Hepatitis A Vaccine Price by Type
        4.3.1 Global Hepatitis A Vaccine Price by Type (2017-2022)
        4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Hepatitis A Vaccine Sales by Application
        5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Hepatitis A Vaccine Revenue by Application
        5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Hepatitis A Vaccine Price by Application
        5.3.1 Global Hepatitis A Vaccine Price by Application (2017-2022)
        5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Hepatitis A Vaccine Market Size by Type
        6.1.1 North America Hepatitis A Vaccine Sales by Type (2017-2028)
        6.1.2 North America Hepatitis A Vaccine Revenue by Type (2017-2028)
    6.2 North America Hepatitis A Vaccine Market Size by Application
        6.2.1 North America Hepatitis A Vaccine Sales by Application (2017-2028)
        6.2.2 North America Hepatitis A Vaccine Revenue by Application (2017-2028)
    6.3 North America Hepatitis A Vaccine Market Size by Country
        6.3.1 North America Hepatitis A Vaccine Sales by Country (2017-2028)
        6.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Hepatitis A Vaccine Market Size by Type
        7.1.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2017-2028)
    7.2 Europe Hepatitis A Vaccine Market Size by Application
        7.2.1 Europe Hepatitis A Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Hepatitis A Vaccine Revenue by Application (2017-2028)
    7.3 Europe Hepatitis A Vaccine Market Size by Country
        7.3.1 Europe Hepatitis A Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Hepatitis A Vaccine Market Size by Type
        8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Hepatitis A Vaccine Market Size by Application
        8.2.1 Asia Pacific Hepatitis A Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Hepatitis A Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Hepatitis A Vaccine Market Size by Region
        8.3.1 Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Hepatitis A Vaccine Market Size by Type
        9.1.1 Latin America Hepatitis A Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Hepatitis A Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Hepatitis A Vaccine Market Size by Application
        9.2.1 Latin America Hepatitis A Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Hepatitis A Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Hepatitis A Vaccine Market Size by Country
        9.3.1 Latin America Hepatitis A Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Hepatitis A Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Hepatitis A Vaccine Market Size by Type
        10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Hepatitis A Vaccine Market Size by Application
        10.2.1 Middle East and Africa Hepatitis A Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Hepatitis A Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Hepatitis A Vaccine Market Size by Country
        10.3.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GSK
        11.1.1 GSK Corporation Information
        11.1.2 GSK Overview
        11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GSK Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GSK Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Corporation Information
        11.3.2 Sanofi Overview
        11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Recent Developments
    11.4 Sinovac
        11.4.1 Sinovac Corporation Information
        11.4.2 Sinovac Overview
        11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sinovac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sinovac Recent Developments
    11.5 Zhejiang Pukang
        11.5.1 Zhejiang Pukang Corporation Information
        11.5.2 Zhejiang Pukang Overview
        11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Zhejiang Pukang Recent Developments
    11.6 Changchun Institute of Biological
        11.6.1 Changchun Institute of Biological Corporation Information
        11.6.2 Changchun Institute of Biological Overview
        11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Changchun Institute of Biological Recent Developments
    11.7 KM Biologics
        11.7.1 KM Biologics Corporation Information
        11.7.2 KM Biologics Overview
        11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 KM Biologics Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 KM Biologics Recent Developments
    11.8 IMBCA
        11.8.1 IMBCA Corporation Information
        11.8.2 IMBCA Overview
        11.8.3 IMBCA Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 IMBCA Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 IMBCA Recent Developments
    11.9 ChangSheng
        11.9.1 ChangSheng Corporation Information
        11.9.2 ChangSheng Overview
        11.9.3 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 ChangSheng Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 ChangSheng Recent Developments
    11.10 Convac
        11.10.1 Convac Corporation Information
        11.10.2 Convac Overview
        11.10.3 Convac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Convac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Convac Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Hepatitis A Vaccine Industry Chain Analysis
    12.2 Hepatitis A Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Hepatitis A Vaccine Production Mode & Process
    12.4 Hepatitis A Vaccine Sales and Marketing
        12.4.1 Hepatitis A Vaccine Sales Channels
        12.4.2 Hepatitis A Vaccine Distributors
    12.5 Hepatitis A Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Hepatitis A Vaccine Industry Trends
    13.2 Hepatitis A Vaccine Market Drivers
    13.3 Hepatitis A Vaccine Market Challenges
    13.4 Hepatitis A Vaccine Market Restraints
14 Key Findings in The Global Hepatitis A Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Inactivated Vaccine
    Table 3. Major Manufacturers of Live Attenuated Vaccine
    Table 4. Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
    Table 7. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
    Table 9. Global Hepatitis A Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Hepatitis A Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Hepatitis A Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Hepatitis A Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Hepatitis A Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Hepatitis A Vaccine Sales by Manufacturers (2017-2022) & (K Unit)
    Table 15. Global Hepatitis A Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Hepatitis A Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Hepatitis A Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2021)
    Table 21. Hepatitis A Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Hepatitis A Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Hepatitis A Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 26. Global Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 27. Global Hepatitis A Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Hepatitis A Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Hepatitis A Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Hepatitis A Vaccine Revenue Share by Type (2023-2028)
    Table 33. Hepatitis A Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Hepatitis A Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 36. Global Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 37. Global Hepatitis A Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Hepatitis A Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Hepatitis A Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Hepatitis A Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Hepatitis A Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Hepatitis A Vaccine Revenue Share by Application (2023-2028)
    Table 43. Hepatitis A Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Hepatitis A Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 46. North America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 47. North America Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 50. North America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 51. North America Hepatitis A Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Hepatitis A Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
    Table 54. North America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
    Table 55. North America Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 58. Europe Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 59. Europe Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 62. Europe Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 63. Europe Hepatitis A Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Hepatitis A Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
    Table 66. Europe Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
    Table 67. Europe Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 70. Asia Pacific Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 71. Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 74. Asia Pacific Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 75. Asia Pacific Hepatitis A Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Hepatitis A Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
    Table 78. Asia Pacific Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
    Table 79. Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Hepatitis A Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 82. Latin America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 83. Latin America Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 86. Latin America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 87. Latin America Hepatitis A Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Hepatitis A Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
    Table 90. Latin America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
    Table 91. Latin America Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 94. Middle East and Africa Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 95. Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 98. Middle East and Africa Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 99. Middle East and Africa Hepatitis A Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Hepatitis A Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
    Table 102. Middle East and Africa Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
    Table 103. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. GSK Corporation Information
    Table 106. GSK Description and Major Businesses
    Table 107. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. GSK Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. GSK Recent Developments
    Table 110. Merck Corporation Information
    Table 111. Merck Description and Major Businesses
    Table 112. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Merck Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Merck Recent Developments
    Table 115. Sanofi Corporation Information
    Table 116. Sanofi Description and Major Businesses
    Table 117. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Sanofi Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Sanofi Recent Developments
    Table 120. Sinovac Corporation Information
    Table 121. Sinovac Description and Major Businesses
    Table 122. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Sinovac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Sinovac Recent Developments
    Table 125. Zhejiang Pukang Corporation Information
    Table 126. Zhejiang Pukang Description and Major Businesses
    Table 127. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Zhejiang Pukang Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Zhejiang Pukang Recent Developments
    Table 130. Changchun Institute of Biological Corporation Information
    Table 131. Changchun Institute of Biological Description and Major Businesses
    Table 132. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Changchun Institute of Biological Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Changchun Institute of Biological Recent Developments
    Table 135. KM Biologics Corporation Information
    Table 136. KM Biologics Description and Major Businesses
    Table 137. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. KM Biologics Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. KM Biologics Recent Developments
    Table 140. IMBCA Corporation Information
    Table 141. IMBCA Description and Major Businesses
    Table 142. IMBCA Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. IMBCA Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. IMBCA Recent Developments
    Table 145. ChangSheng Corporation Information
    Table 146. ChangSheng Description and Major Businesses
    Table 147. ChangSheng Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. ChangSheng Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. ChangSheng Recent Developments
    Table 150. Convac Corporation Information
    Table 151. Convac Description and Major Businesses
    Table 152. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Convac Hepatitis A Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Convac Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Hepatitis A Vaccine Distributors List
    Table 158. Hepatitis A Vaccine Customers List
    Table 159. Hepatitis A Vaccine Market Trends
    Table 160. Hepatitis A Vaccine Market Drivers
    Table 161. Hepatitis A Vaccine Market Challenges
    Table 162. Hepatitis A Vaccine Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hepatitis A Vaccine Product Picture
    Figure 3. Global Hepatitis A Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Inactivated Vaccine Product Picture
    Figure 4. Live Attenuated Vaccine Product Picture
    Figure 5. Global Hepatitis A Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Government Institution
    Figure 7. Private Sector
    Figure 8. Other
    Figure 9. Hepatitis A Vaccine Report Years Considered
    Figure 10. Global Hepatitis A Vaccine Sales 2017-2028 (K Unit)
    Figure 11. Global Hepatitis A Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Hepatitis A Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Hepatitis A Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global Hepatitis A Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit)
    Figure 17. North America Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit)
    Figure 19. Europe Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit)
    Figure 21. Asia-Pacific Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit)
    Figure 23. Latin America Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit)
    Figure 25. Middle East & Africa Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Hepatitis A Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Hepatitis A Vaccine in the World: Market Share by Hepatitis A Vaccine Revenue in 2021
    Figure 28. Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Hepatitis A Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America Hepatitis A Vaccine Revenue Share by Country (2017-2028)
    Figure 39. U.S. Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Hepatitis A Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe Hepatitis A Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Hepatitis A Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Hepatitis A Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Hepatitis A Vaccine Sales Share by Country (2017-2028)
    Figure 73. Latin America Hepatitis A Vaccine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Hepatitis A Vaccine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Hepatitis A Vaccine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. Hepatitis A Vaccine Value Chain
    Figure 87. Hepatitis A Vaccine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
Frequently Asked Questions
Hepatitis A Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hepatitis A Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hepatitis A Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

High Heels

High Heels market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More

Hydrogen Peroxide

Hydrogen Peroxide market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More